Tzu Chi Medical Journal
Volume 21, Issue 2 , Pages 118-122, June 2009

High Incidence of Transitional Cell Carcinoma in Kidney Transplant Recipients in Eastern Taiwan

  • Jing-Liang Chen

      Affiliations

    • Department of Urology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Graduate Institute of Human Genetics, Tzu Chi University, Hualien, Taiwan
    • ,
  • Guan-Jin Ho

      Affiliations

    • Department of Surgery, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • ,
  • Ying-Chin Yang

      Affiliations

    • Department of Surgery, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • ,
  • Ming-Hui Shih

      Affiliations

    • Department of Nursing, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • ,
  • Kuei-Chun Chou

      Affiliations

    • Department of Nursing, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • ,
  • Ming-Che Lee

      Affiliations

    • Department of Surgery, Buddhist Tzu Chi General Hospital, Hualien, Taiwan
    • Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan
    • Corresponding Author InformationCorresponding author. Department of Surgery, Buddhist Tzu Chi General Hospital, 707, Section 3, Chung-Yang Road, Hualien, Taiwan

Received 4 July 2008; received in revised form 23 July 2008; accepted 8 August 2008.

Article Outline

Abstract 

Objective

A higher incidence of urinary tract transitional cell carcinoma (TCC) has been reported in both long-term hemodialysis patients and kidney transplant (KTX) recipients in Taiwan than in other countries. Herein, we report a high incidence of urinary tract malignancy, especially TCC, in KTX recipients in eastern Taiwan.

Patients and Methods

We retrospectively reviewed the medical records, clinical data, and outcomes of 102 KTX recipients in Tzu Chi General Hospital from 1992 to 2008. Overall graft and patient survival, incidence of posttransplant malignancy, and cumulative incidence of TCC after KTX were investigated.

Results

During a mean follow-up of 45.5 ± 38.5 months after KTX, 12 malignancies were diagnosed in nine recipients. The incidence of post-transplant malignancy in all recipients was 8.2%. TCC was diagnosed in four patients, and all these patients presented with painless gross hematuria and hydronephrosis. Three patients had tumor involvement in the upper urinary tract. TCC occurred at a mean of 56 ± 70.7 months after KTX, and the cumulative incidence of TCC was 4.7% in the first 3 years after transplant. Only one patient with triple cancer died of disseminated cholangiocarcinoma of the distal common bile duct during a mean follow-up of 15.8 ± 9.5 months after surgical treatment of TCC.

Conclusion

KTX recipients are at extremely high risk of TCC in eastern Taiwan, with an incidence of 3.9%. The cardinal signs of posttransplant TCC are painless gross hematuria and hydronephrosis of the native kidney. Careful, timely urological screening in KTX recipients warrants early diagnosis and good prognosis after aggressive surgical management.

Keywords:  Kidney transplantation , Posttransplant malignancy , Recipient , Transitional cell carcinoma

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Newstead CG . Assessment of risk of cancer after renal trans plantation . Lancet . 1998;351:610–611
  2. Penn I . Second malignant neoplasms associated with immunosuppressive medications . Cancer . 1976;37(Suppl 2):1024–1032
  3. Penn I . Malignancies associated with renal transplantation . Urology . 1977;10(Suppl 1):57–63
  4. Birkeland SA , Lokkegaard H , Storm HH . Cancer risk in patients on dialysis and after renal transplantation . Lancet . 2000;355:1886–1887
  5. Gaya SB , Rees AJ , Lechler RI , Williams G , Mason PD . Malignant disease in patients with long-term renal transplants . Transplantation . 1995;59:1705–1709
  6. Gifford RR , Wofford JE , Edwards WG . Carcinoma of the bladder in renal transplant patients. A case report and collective review of cases . Clin Transplant . 1998;12:65–69
  7. Birkeland SA , Storm HH , Lamm LU , et al.   Cancer risk after renal transplantation in the Nordic countries, 1964–1986 . Int J Cancer . 1995;60:183–189
  8. Wu MJ , Lian JD , Yang CR , et al.   High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan . Am J Kidney Dis . 2004;43:1091–1097
  9. Penn I . Occurrence of cancers in immunosuppressed organ transplant recipients . Clin Transpl . 1998;147–158
  10. Alonso A , Oliver J . Causes of death and mortality risk factors . Nephrol Dial Transplant . 2004;19(Suppl 3):iii8–ii10
  11. Campistol JM . Minimizing the risk of posttransplant malignancy . Transplantation . 2009;87(8 Suppl):S19–S22
  12. Ou JH , Pan CC , Lin JS , et al.   Transitional cell carcinoma in dialysis patients . Eur Urol . 2000;37:90–94
  13. Wimmer CD , Rentsch M , Crispin A , et al.   The janus face of immunosuppression— de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich . Kidney Int . 2007;71:1271–1278
  14. Penn I . Primary kidney tumors before and after renal transplantation . Transplantation . 1995;59:480–485
  15. Wang HB , Hsieh HH , Chen YT , Chiang CY , Cheng YT . The outcome of post-transplant transitional cell carcinoma in 10 renal transplant recipients . Clin Transplant . 2002;16:410–413
  16. Satoh S , Tsuchiya N , Habuchi T , Ishiyama T , Seimo K , Kato T . Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis . J Urol . 2005;174:1749–1753
  17. Fukatsu T , Nishikawa A , Yonemura S , et al.   Two cases of renal cell carcinoma arising in the native kidney following renal transplantation—clinical study and review of 26 cases reported in Japan . Hinyokika Kiyo . 2004;50:81–85
  18. Chen KS , Lai MK , Huang CC , Chu SH , Leu ML . Urologic cancers in uremic patients . Am J Kidney Dis . 1995;25:694–700
  19. Swindle P , Falk M , Rigby R , Petrie J , Hawley C , Nicol D . Transitional cell carcinoma in renal transplant recipients: the influence of compound analgesics . Br J Urol . 1998;81:229–233
  20. Kliem V , Thon W , Krautzig S , et al.   High mortality from urothelial carcinoma despite regular tumor screening in patients with analgesic nephropathy after renal transplantation . Transpl Int . 1996;9:231–235
  21. Nortier JL , Martinez MC , Schmeiser HH , et al.   Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) . N Engl J Med . 2000;342:1686–1692
  22. Nortier JL , Vanherweghem JL . Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) . Toxicology . 2002;181–182:577–580
  23. Liao CH , Chueh SC , Lai MK , Chen J . Transitional cell carcinoma in renal transplant recipients . Transplant Proc . 2004;36:2152–2153

PII: S1016-3190(09)60022-7

doi:10.1016/S1016-3190(09)60022-7

Tzu Chi Medical Journal
Volume 21, Issue 2 , Pages 118-122, June 2009

Article Tools